INS and fatty liver disease: Although CK2α ablation exerted little response in LFD‐fed mice, it markedly alleviated HFD‐induced changes, including hepatic architectural alterations, liver steatosis, blood profiles indicative of liver injury, lipid droplet formation, plasm insulin levels, and the HOMA‐IR index.